CCR5 and atherosclerosis: We evaluated the serum levels of atherosclerosis-related inflammatory factors in mice treated with CCR5-overexpressing EPCs using mouse atherosclerosis antibody array I. Six weeks after treatment, nine proteins were identified with significant fold changes according to the heatmap diagram (Figure 6A).